stockrow
Friday 6 November 2026
Export STE’s income statement to Excel — free account
STERIS plc
STE Healthcare Medical Devices
STERIS plc’s revenue for fiscal 2026 (year ended March 2026) was $5.9 billion, up 8.73% from fiscal 2025.
- Revenue
- +8.79%
- EPS
- +12.8%
- Free cash flow
- +43.6%
- Total debt
- −0.21%
Quarter to September 2026, against a year earlier
252.70
1.42
−0.56%
Follow STE
Alert me
STERIS plc (STE) P/S ratio
As of 5 November 2026, STERIS plc (STE) trades at a P/S ratio of 4.0×. Over the past ten years it has ranged from 2.0× (August 2015) to 6.4× (December 2021); the current reading is higher than 47% of that period. That is above the Medical Devices industry median of 2.5× and above the Healthcare sector median of 3.5×.
P/S ratio, daily
Embed this chart
Annual newest first
| Period | P/S ratio | Change |
|---|---|---|
| FY2026 | 3.7× | (10.63%) |
| FY2025 | 4.1× | (3.68%) |
| FY2024 | 4.2× | 1.08% |
| FY2023 | 4.2× | (24.70%) |
| FY2022 | 5.6× | 6.91% |
| FY2021 | 5.2× | 33.40% |
| FY2020 | 3.9× | 1.07% |
| FY2019 | 3.9× | 31.14% |
| FY2018 | 3.0× | 30.00% |
| FY2017 | 2.3× | 1.27% |
Quarterly newest first
| Period | P/S ratio | Change |
|---|---|---|
| Sep 2026 | 3.3× | (2.64%) |
| Jun 2026 | 3.4× | (6.95%) |
| Mar 2026 | 3.7× | (14.36%) |
| Dec 2025 | 4.3× | 0.05% |
| 43 more quarters | Free account |
Against its own ten years
Low 2.0×
High 6.4×
Ten-year median
4.1×
Current reading's percentile
43
P/S ratio against peers
| Company | P/S ratio |
|---|---|
| SNN Smith & Nephew SNATS, Inc. compare | 1.4× |
| PHG Koninklijke Philips N.V. compare | 1.4× |
| GEHC GE HealthCare Technologies Inc. compare | 1.7× |
| ZBH Zimmer Biomet Holdings, Inc. compare | 2.4× |
| GMED Globus Medical, Inc. compare | 3.5× |
| STE STERIS plc | 4.0× |
| DXCM DexCom, Inc. compare | 6.2× |
| PEN Penumbra, Inc. compare | 8.1× |
| GKOS Glaukos Corporation compare | 18.8× |
| Medical Devices industry median | 2.5× |
| Healthcare sector median | 3.5× |
| Market median | 1.9× |
What P/S ratio is
Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.
(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)
More on STE
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement